Roswell, Georgia – CorMatrix Cardiovascular announced today that it has received U.S. Food and Drug Administration (FDA) clearance to market the CorMatrix CanGaroo ECM Envelope for use with cardiac implantable electronic devices (CIED's) including pacemakers and implantable cardioverter defibrillators (ICD's).
News Well, Press Release, Regulatory/Clearance, 510(k), Cardiac Rhythm Management, Food & Drug Administration (FDA), Surgical
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1pMNMJ8
Cap comentari:
Publica un comentari a l'entrada